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Abstract. 
 
Many cells (e.g., epithelial cells) require at-
tachment to the extracellular matrix (ECM) to survive, 
a phenomenon known as anchorage-dependent cell 
survival. Disruption of the cell–ECM interactions medi-
ated by the integrin receptors results in apoptosis. Focal 
adhesion kinase (FAK), a 125-kD protein tyrosine ki-
nase activated by integrin engagement, appears to be 
involved in mediating cell attachment and survival. Pro-
line-rich tyrosine kinase 2 (PYK2), also known as cellu-
 
lar adhesion kinase 
 
b
 
 (CAK
 
b
 
) and related adhesion fo-
cal tyrosine kinase, is a second member of the FAK 
subfamily and is activated by an increase in intracellu-
lar calcium levels, or treatment with TNF
 
a
 
 and UV 
light. However, the function of PYK2 remains largely 
unknown. In this study, we show that over-expression 
of PYK2, but not FAK, in rat and mouse fibroblasts 
leads to apoptotic cell death. Using a series of deletion 
mutants and chimeric fusion proteins of PYK2/FAK, 
 
we determined that the NH
 
2
 
-terminal domain and ty-
rosine kinase activity of PYK2 were required for the 
efficient induction of apoptosis. Furthermore, the apop-
tosis mediated by PYK2 could be suppressed by 
over-expressing catalytically active v-Src, c-Src, phos-
phatidylinositol-3-kinase, or Akt/protein kinase B. In 
addition, it could also be suppressed by overexpressing 
an ICE or ICE-like proteinase inhibitor, crmA, but not 
Bcl2. Collectively, our results suggest that PYK2 and 
FAK, albeit highly homologous in primary structure, 
appear to have different functions; FAK is required for 
cell survival, whereas PYK2 induces apoptosis in fibro-
blasts.
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1. 
 
Abbreviations used in this paper
 
: ECM, extracellular matrix; FAK, focal
adhesion kinase; FRNK, FAK-related nonkinase; FAT, focal adhesion
targeting domain; GST, glutathione-S-transferase; PI3 kinase, phosphati-
dylinositol-3-kinase.
 
H
 
omeostasis 
 
of multicellular organisms is con-
trolled not only by the proliferation and differen-
tiation of cells but also by cell death (Raff, 1992).
Programmed cell death, or apoptosis, is characterized by
the presence of nuclear and cytoplasmic condensation and
segmentation and is an important regulatory event in em-
bryogenesis, metamorphosis, endocrine-dependent tissue
atrophy, and normal tissue turnover (Raff, 1992; Nagata
and Golstein, 1995; Steller, 1995; Muzio et al., 1996). Dis-
regulation of apoptosis contributes to the pathogenesis of
several diseases, including cancers, neurodegenerative dis-
orders, immunodeficiency, and autoimmune diseases (Thomp-
son, 1995). Although the intracellular mediators that induce
apoptosis are beginning to be defined, relatively little is
known about the mechanisms by which cell death programs
are executed.
Apoptosis can be triggered by a variety of extrinsic and
intrinsic signals. Extrinsic inducers of apoptosis include
TNF family proteins (e.g., Fas ligand and TNF
 
a
 
), calcium,
growth factor withdrawal, and loss of extracellular matrix
(ECM)
 
1
 
 attachment (Nagata and Golstein, 1995; Thomp-
son, 1995). These extrinsic signals induce apoptosis in a
wide variety of cell types. Intrinsic inducers of apoptosis
comprise a number of genes conserved throughout evolu-
tion, including members of interleukin-1
 
b
 
 converting en-
zyme (ICE) proteinase family, Bcl2 family (e.g., Bcl2s, Bad,
and Bax), and p53 (Ellis et al., 1991; Vaux et al., 1994).
Apoptosis can be suppressed by a variety of extrinsic and
intrinsic signals, including growth factors (e.g., IGF1, NGF,
and CNTF), signaling molecules activated by these growth
factors (e.g., phosphatidylinositol-3-kinase [PI3 kinase]),
Bcl2 family proteins (e.g., Bcl2 and Bclxl), and proteinase
inhibitors (e.g., crmA; Kapeller and Cantly, 1994; Nagata
and Golstein, 1995; Steller, 1995; Thompson, 1995; Yao
and Cooper, 1995).
Integrin engagement and activation of FAK are impli-
cated in a number of signaling pathways, including ones
that lead to anchorage-dependent cell survival (Burridge
and Chrzanowska-Wodnicka, 1996; Frisch et al., 1996;
Hungerford et al., 1996; Parsons, 1996; Xu et al., 1996).
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FAK is a prototypic member of a family of nonreceptor
protein tyrosine kinases, containing a central catalytic do-
main and large NH
 
2
 
- and COOH-terminal noncatalytic re-
gions that are devoid of SH2 and SH3 domains (Hanks et
al., 1992; Schaller et al., 1992). FAK is enriched in the
brain and expressed in most cell lines and tissues exam-
ined (Andre and Becker-Andre, 1993; Grant et al., 1995).
In some cell types, the COOH-terminal domain of pp125
 
FAK
 
is expressed autonomously as a 41-kD protein termed fo-
cal adhesion kinase (FAK)-related nonkinase (FRNK)
(Schaller et al., 1993). FAK is activated by many diverse
stimuli, including v-Src transformation (Schaller et al., 1992),
attachment to the ECM (Guan and Shalloway, 1992;
Schaller et al., 1992), and exposure to growth factors (e.g.,
PDGF; Rankin and Rozengurt, 1994), neuropeptides (e.g.,
bombesin; Rozengurt, 1991; Zachary et al., 1992), and
lysophosphatidic acid (Moolenaar, 1991). Clustering of in-
tegrins through binding to the ECM leads to the tyrosine
phosphorylation of FAK (Guan and Shalloway, 1992;
Schaller et al., 1992). Phosphorylation of FAK on tyrosine
397 creates a high affinity binding site for the SH2 do-
mains of Src and Fyn, both of which are associated with ac-
tivated FAK (Cobb et al., 1994; Schaller et al., 1994).
Phosphorylation of FAK on tyrosine residues present in
the COOH-terminal domain leads to the association of
various other SH2 domain–containing signaling proteins,
including Grb2 (Schlaepfer et al., 1994) and the p85 sub-
unit of PI3 kinase (Chen and Guan, 1994
 
b
 
; Guinebault et
al., 1995). In addition, the proline-rich regions in the
COOH-terminal domain of FAK direct the binding to
p130
 
cas
 
 (Crk-associated substrate) and Graf (GTPase reg-
ulator associated with FAK) in an SH3 domain-dependent
manner (Polte and Hanks, 1995; Harte et al., 1996; Hilde-
brand et al., 1996). The COOH-terminal domain of FAK
can also associate with the cytoskeletal proteins paxillin
and talin (Bellis et al., 1995; Chen et al., 1995; Hildebrand
et al., 1995; Tachibana et al., 1995). Inclusive within the
COOH-terminal domain is a 140-amino acid sequence
that is both necessary and sufficient for the targeting of
FAK to focal adhesions, called the focal adhesion target-
ing domain (FAT; Hildebrand et al., 1993). FAK is be-
lieved to play an important role in regulating signaling
events initiated by the activation of various membrane re-
ceptors that induce cytoskeletal rearrangement (Parsons,
1996). Cells microinjected with reagents that attenuate the
activity of FAK (e.g., anti-sense oligonucleotides and anti-
FAK antibodies) undergo apoptosis (Hungerford et al.,
1996; Xu et al., 1996). Cells expressing constitutively active
CD2-FAK are resistant to apoptosis when detached from
the ECM (Frisch et al., 1996), suggesting that FAK may be
involved in mediating the anchorage-dependent cell sur-
vival.
Recently, a second member of the FAK subfamily, pro-
line-rich tyrosine kinase 2 (PYK2), also known as cellular
adhesion kinase 
 
b
 
 (CAK
 
b
 
) and related adhesion focal ty-
rosine kinase (RAFTK), has been identified (Avraham et
al., 1995; Lev et al., 1995; Sasaki et al., 1995). PYK2, a 116-kD
cytoplasmic protein tyrosine kinase, is rapidly phosphory-
lated on tyrosine residues in response to various stimuli,
including elevation of the intracellular calcium levels, acti-
vation of protein kinase C, and exposure to stress factors
(e.g., UV light, TNF
 
a
 
; Lev et al., 1995; Tokiwa et al.,
 
1996). PYK2 is highly enriched in the brain and is ex-
pressed in fewer tissues and cell lines (e.g., PC12 cells, and
many hematopoietic cell lines; Avraham et al., 1995; Lev
et al., 1995; Sasaki et al., 1995; Salgia et al., 1996). The re-
stricted expression of PYK2, as compared to FAK, sug-
gests that they may mediate distinct functions. FAK and
PYK2 are highly homologous to each other, sharing 45%
overall sequence identity and 60% identity in the catalytic
domain. Several tyrosine residues are conserved between
FAK and PYK2, including the binding site for the SH2 do-
mains of Src and Fyn (Y
 
397
 
 in FAK, Y
 
402
 
 in PYK2) and the
putative binding site for the SH2 domain of Grb2 (Y
 
925
 
 in
FAK, Y
 
881
 
 in PYK2; Cobb et al., 1994; Schaller et al., 1994;
Schlaepfer et al., 1994; Avraham et al., 1995; Lev et al.,
1995; Sasaki et al., 1995; Dikic et al., 1996). In addition,
PYK2 also contains the putative “FAT” domain and the
proline-rich sequences responsible for mediating the bind-
ing of p130
 
cas
 
 and Graf. Given the high degree of sequence
similarity between PYK2 and FAK, it is possible that
PYK2 interacts with some or many of the FAK-binding
partners. Indeed, tyrosine-phosphorylated PYK2 is able to
bind to the SH2 domain of Grb2 in a similar manner to
FAK, which is thought to lead to the activation of MAPK
pathway in PC12 cells (Lev et al., 1995). While PYK2 is
believed to play a role in regulating neurotransmission or
neuroplasticity by phosphorylating potassium channels
(Lev et al., 1995), other functions of PYK2 are still uniden-
tified.
In this report we demonstrate that over-expression of
PYK2 in both fibroblastic and epithelial cell lines (e.g., rat-1,
mouse 10T1/2, swiss 3T3, quail QT6, and human embry-
onic kidney 293 cells [HEK 293]) leads to apoptosis. The
NH
 
2
 
-terminal domain and tyrosine kinase activity of PYK2
are required for its full apoptotic activity. Furthermore, we
show that the PYK2-mediated apoptosis can be suppressed
by over-expression of catalytically active c-Src, v-Src, PI3 ki-
nase, and Akt/PKB. It could also be suppressed by over-
expressing crmA, but not Bcl2. These data demonstrate
that while PYK2 and FAK are structurally similar, each
has the capacity to mediate distinctly different signaling
responses.
 
Materials and Methods
 
Reagents and Cell Lines
 
Rabbit polyclonal antisera recognizing PYK2 were raised using a glu-
tathione-S-transferase (GST) fusion protein containing the COOH-termi-
nal 400 amino acids of rat PYK2 (amino acid 587 to 988). Monoclonal an-
tibodies and goat polyclonal antibody recognizing NH
 
2
 
-terminal PYK2
domain were purchased from Santa Cruz Biotechnology (Santa Cruz, CA;
anti-myc and anti-PYK2) or Transduction Laboratories (Lexington, KY;
anti-phosphotyrosine). Propidium iodide was purchased from Sigma
Chemical Co. (St. Louis, MO). TUNEL kit (Apoptag kit) was purchased
from Boehringer Mannheim (Indianapolis, IN). GST-c-Jun was purchased
from Clonetech (Palo Alto, CA). LA29, a v-Src temperature-sensitive cell
line, was provided by M. Weber (University of Virginia, Charlottesville,
VA). Mouse fibroblastic 10T1/2, 5HD47 (c-Src), pm430 (kinase inactive
c-Src), and dl155 (SH2 defective c-Src) cell lines were provided by S. Parsons
(University of Virginia, Charlottesville, VA). HEK 293 cells were pro-
vided by Q.-H. Song (Columbia University, New York, NY).
 
Expression Vectors
 
The cDNAs of PYK2 (CAK
 
b
 
, kindly provided by T. Sasaki, Sapporo 
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Medical University, Sapporo, Japan), FAK, and FRNK were subcloned
into expression vectors, either downstream of a c-myc epitope tag
(MEQKLISEEDL) under the control of the cytomegalovirus (CMV) pro-
moter (pCMV-c-Myc; Evan et al., 1985) or downstream of GST under the
control of the elongation factor 1
 
a
 
 (EF1
 
a
 
) promoter (pEBG). The “FAT”
domain deletion mutant (PYK2
 
D
 
936-1009) was generated by inserting an
in-frame stop codon between XbaI site in PYK2 and the NheI site in
pCMV-c-Myc. The kinase and COOH-terminal domain deletion mutant
(PYK2
 
D
 
250-1009) was generated by inserting an in-frame stop codon be-
tween the Nsi site in PYK2 and the Nsi site in pCMV-c-Myc. NH
 
2
 
-termi-
nal deletion mutants, the kinase inactive (lysine [K] 457 to alanine [A]),
and autophosphorylation site (tyrosine [Y] 402 to phenylalanine [F]) mu-
tants were generated by PCR (Ho et al., 1989). The chimeric constructs of
PYK2/FAK1 and PYK2/FAK2 were generated by in-frame ligation of in-
dividual PCR fragments. In construct PYK2/FAK1, the NH
 
2
 
-terminal do-
main of PYK2 (amino acids 2 to 385) was amplified by PCR and fused
with the PCR fragments of the kinase and COOH-terminal domains of
FAK (amino acids 380 to 1052). In construct PYK2/FAK2, the NH
 
2
 
-termi-
nal and kinase domain of PYK2 (amino acids 2 to 695) was ligated with
the COOH-terminal domain of FAK (amino acids 692 to 1052). The au-
thenticity of all mutants was verified by DNA sequencing. The constructs
encoding constitutively active and inactive PI3 kinase and Akt were gifts
from Anke Klippel (Chiron Corporation, Emeryville, CA; Klippel et al.,
1996).
 
Cell Culture and Transfections
 
Rat-1, mouse 10T1/2, and Cos-1 cells were maintained in DME containing
10% fetal calf serum, 100 
 
m
 
g/ml penicillin G, and 100 mg/ml Streptomycin
(GIBCO BRL, Gaithersburg, MD). LA29, 5HD47, pm430, and dl155 cell
lines were maintained in the above medium containing G418 (Sigma
Chemical Co.). HEK 293 cells were maintained in DME/F12 (1:1) me-
dium with the same additives. Cells were plated 12 h before transfection at
a density of 10
 
4
 
 cells/22 mm
 
2
 
 coverslip (VWR Scientific, West Chester, PA).
Cells were transfected with 30–40 
 
m
 
l of lipofectamine (GIBCO BRL) with
various constructs (3 
 
m
 
g DNA) with or without 1 
 
m
 
g of pCMV 
 
b
 
-galac-
tosidase in 1.6 ml of DME-serum free medium (GIBCO BRL). After in-
cubation for 5 h, 1 ml of serum-containing DME media was added. 30 h
later, cells were fixed with 4% paraformaldehyde for immunostaining or
fixed with 0.5% glutaraldehyde for 
 
b
 
-galactosidase staining as described
below.
 
Apoptosis Assays
 
The morphology of transfected cells was examined by 
 
b
 
-galactosidase
staining or immunostaining of PYK2 using antibodies against PYK2 or the
c-Myc epitope tag. For 
 
b
 
-galactosidase staining, fixed cells were washed
with PBS three times, each for 5 min, and incubated in PBS containing 20
mM K
 
2
 
Fe(CN)6, 20 mM K
 
2
 
Fe(CN)6.3H
 
2
 
O, 1 mM MgCl
 
2
 
, and 0.5 mg/ml
X-gal (5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
d
 
-galactopyranoside) until a suitable
color developed (
 
z
 
1–2 h). For immunostaining, fixed cells were incubated
with the primary antibody against PYK2 (1:500 dilution) at 37
 
8
 
C for 1 h
and visualized with a fluorescence-conjugated anti–rabbit or anti–mouse
secondary antibody (1:300 dilution). Condensed or fragmented DNA was
detected in situ with propidium iodide or fluorescence-dUTP using termi-
nal deoxynucleotidyl transferase (Apoptag) as described previously (Gab-
rieli et al., 1992; Xiong and Montell, 1995). These cells were double labeled
with anti-PYK2 antibodies to monitor the protein expression. Apoptotic
index was determined by counting the number of apoptotic cells, which
expressed either 
 
b
 
-galactosidase or PYK2, divided by the total number of
 
b
 
-galactosidase or PYK2-expressing cells. For each experiment, a mini-
mum of 200 cells that expressed 
 
b
 
-galactosidase or PYK2 was counted.
Each construct was examined at least three times.
 
Immunoprecipitation
 
For immunoprecipitation, 500 
 
m
 
g of cell lysates was incubated with anti-
PYK2 antibodies at 4
 
8
 
C for 1 h in a final volume of 1 ml RIPA buffer. Af-
ter the addition of protein A-agarose beads, the reaction was incubated at
4
 
8
 
C for another hour. Immunocomplexes were purified and subjected to
immunoblotting using antiphosphotyrosine and anti-PYK2 antibodies.
 
Results
 
Expression of PYK2 Induced Morphological Changes
in rat-1 Cells
 
To study the function of PYK2, we attempted to generate
rat-1 fibroblastic cell lines stably expressing PYK2. After a
number of failures, we examined the phenotype of rat-1
cells after transient transfection using a vector carrying
cDNA encoding full length PYK2 with an NH
 
2
 
-terminal
c-Myc epitope tag under the control of the CMV promoter
(PYK2-WT). The expression of PYK2 as well as cell mor-
phology were monitored by immunostaining of the cells
using anti-PYK2 antibodies, anti-c-Myc (9E10) mono-
clonal antibodies, or by 
 
b
 
-galactosidase staining of cells
that were co-transfected with a reporter plasmid contain-
ing the cDNA encoding 
 
b
 
-galactosidase (pCMV-
 
b
 
-gal).
As shown in Fig. 1, the transfection with a control pCMV
vector with or without pCMV-
 
b
 
-gal had no effect on cell
morphology (Fig. 1, 
 
A
 
 and 
 
B
 
). However, rat-1 cells ex-
pressing the PYK2 protein, identified by both PYK2 or
Myc immunostaining or 
 
b
 
-galactosidase staining, appeared
to be round with condensed cytoplasm, blebbed mem-
brane, and poorly attached to the dish (Fig. 1, 
 
C
 
 and 
 
D
 
).
These morphological changes were specific for PYK2-
expressing rat-1 cells, since the rat-1 cells overexpressing
FAK appeared similar to control cells (Fig. 1, 
 
E
 
 and 
 
F
 
).
Figure 1. Morphological changes of rat-1 cells expressing PYK2.
Rat-1 cells were transiently transfected with pCMV vector (A
and B), pCMV-PYK2-WT (C and D), and pCMV-FAK (E and
F) plasmids without (A, C, and E) and with pCMV-b-galactosi-
dase (B, D, and F). 30 h after transfection, the cells were fixed
with 4% paraformaldehyde and stained with antibodies against
c-Myc (9E10) epitope (A, C, and E), or fixed by 0.5% glutaralde-
hyde and stained for the b-galactosidase activity of the cells
cotransfected with pCMV-b-galactosidase (B, D, and F). 
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Morphologically Altered rat-1 Cells Exhibit
Features of Apoptosis
 
The morphological changes in rat-1 fibroblasts induced by
PYK2 expression was indicative of apoptosis. We used
both propidium iodide staining and TdT-mediated dUTP-
fluorescence nick end labeling (TUNEL) to determine
whether DNA condensation and fragmentation, a hallmark
of apoptosis, occurred in the cells expressing PYK2 (Fisher,
 
1994; Muzio et al., 1996). In parallel, the transfected cells
were also immunostained with either anti-PYK2 or anti-
Myc (9E10) antibodies to monitor the protein expression.
Propidium iodide staining of cells expressing wild-type
PYK2 demonstrated condensed nuclei (Fig. 2, 
 
B
 
 and 
 
D
 
).
This effect was not observed in cells transfected with vec-
tor alone (data not shown) or constructs encoding COOH-
terminal PYK2 protein (PYK2
 
D
 
1-680; Fig. 3, 
 
A
 
 and 
 
C
 
). In
addition, PYK2-expressing cells exhibited DNA fragmen-
tation, detected using modified TUNEL (Fig. 2, 
 
F
 
 and 
 
H
 
),
whereas no fragmentation was observed in cells trans-
fected with the COOH-terminal PYK2, PYK2
 
D
 
1-680 (Fig.
2, 
 
E
 
 and 
 
G
 
). The concomitant induction of cell death with
expression of wild-type PYK2 suggested that the expres-
sion of PYK2 may be directly responsible for the induction
of cell death. Similar morphological changes and apoptosis
were observed after transfection of PYK2 into mouse
10T1/2, swiss 3T3, quail QT6, and HEK 293 cells (data not
shown). In PC12 cells that express significant levels of en-
dogenous PYK2, no detectable cell death was observed
when PYK2 was over-expressed (data not shown).
 
The Full Apoptotic Activity of PYK2 Requires
NH
 
2
 
-terminal and Active Kinase Domains
 
PYK2 contains a central catalytic kinase domain (from
amino  acid 419 to 679), flanked by noncatalytic NH
 
2
 
-termi-
nal (amino acids 1 to 418) and COOH-terminal (amino acids
680 to 1009) domains (Fig. 3). Within the COOH-terminal
region, there are two proline-rich sequences and a putative
FAT domain (Fig. 3). To determine which domains of PYK2
Figure 2. Apoptosis of rat-1 cells expressing PYK2. Rat-1 cells were
transiently transfected with PYK2 COOH-terminal (PYK2D1-680;
A, C, E, and G) and wild-type PYK2 (PYK2-WT; B, D, F, and H)
plasmids. 24–30 h after transfection, the cells were fixed and immu-
nostained with anti-PYK2 antibodies and propidium iodide (A–D).
In a separate experiment, the transfected cells were immuno-
stained using antibodies against PYK2 and labeled with fluores-
cence-conjugated dUTP using terminal transferase (E–H). Nuclei
of rat-1 cells overexpressing PYK2D1-680 with normal morphol-
ogy stained uniformly with propidium iodide, indicating intact
nuclei (C, arrows). Propidium iodide staining of rat-1 cells over-
expressing PYK2-WT showed apoptotic nuclei (condensed, indi-
cated by arrows) in a fraction of cells (D). While there was no
labeling of fluorescence-conjugated dUTP in cells expressing
PYK2D1-680 with normal morphology (G), there was labeling of
dUTP in cells expressing PYK2-WT (H).
Figure 3. Schematic diagrams of PYK2, PYK2 mutants, FAK,
and FAK mutants. The numbers represent the amino acid resi-
dues deleted from wild-type PYK2. The shaded block represents
the kinase domain of PYK2. The putative FAT domain and pro-
line-rich sequences are indicated. The constructs tagged with ei-
ther c-Myc or GST are also indicated. Apoptotic index (mean 6
SEM) was determined by counting the apoptotic PYK2 or FAK-
expressing cells (or PYK2 positive) divided by total number of
PYK2 or FAK expression cells, and listed in the right-hand column.Xiong and Parsons PYK2 Induces Apoptosis 533
were required for its apoptotic activity, we generated a se-
ries of PYK2 deletion mutants, whose structures are sum-
marized in Fig. 3. Mutant proteins were tagged either with
GST or a c-Myc epitope at the NH2 terminus. Transfection
of individual mutant constructs into HEK 293 cells fol-
lowed by Western blotting of cell extracts using anti-
PYK2, antibodies to the c-Myc epitope or GST, confirmed
the expression of mutant proteins of the appropriate mo-
lecular sizes (Fig. 4 A). The apoptotic activity of individual
mutant proteins was tested by transient transfection of rat-1
cells with each mutant construct in the presence or ab-
sence of pCMV b-galactosidase reporter. The “apoptotic
index” for each mutant was determined by counting the
apoptotic blue cells or apoptotic PYK2-expressing cells
and dividing by the total number of transfected cells (total
number of blue or PYK2-expressing cells).
The PYK2-WT demonstrated the highest apoptotic ac-
tivity or apoptotic index (0.97), while the basal apoptotic
index in rat-1 cells transfected with control vector alone
was 0.09–0.13. A significant reduction of the apoptotic in-
dex (0.3–0.5) was observed after transfection with the
NH2-terminal domain deletion mutants (e.g., PYK2D1-88
and PYK2D1-416; Figs. 3 and 4, A and C), suggesting that
the NH2-terminal domain of PYK2 was required for maxi-
mal apoptotic activity. This conclusion was further sup-
ported by the observation that transfection of cells with
the NH2-terminal domain alone (PYK2D250-1009) was
able to induce significant cell death (0.55; Figs. 3 and 4 C).
We next determined if kinase activity was required for
PYK2-induced apoptosis. The kinase-inactive PYK2 (K457A
[PYK2-KD]), containing a lysine (K) to alanine (A) muta-
tion in the ATP-binding site (Fig. 5 A), was transfected
into rat-1 cells. The apoptotic index of rat-1 cells express-
ing the kinase-inactive mutant was 0.6, a significant de-
crease from that of the wild-type, suggesting that PYK2
catalytic activity was required for the maximal apoptotic
activity (Fig. 5 B). This conclusion was further supported
by the observation that the apoptotic index of rat-1 cells
expressing the autophosphorylation mutant PYK2-Y402F,
containing a tyrosine (Y) 402 to (F) mutant (Fig. 5 A), was
also significantly reduced to 0.41 (Fig. 5 B). In contrast to
the cells expressing PYK2, cells expressing wild-type FAK,
an autophosphorylation mutant (Y397F), or the COOH-
terminal domain of FAK (FRNK) exhibited a low level of
apoptosis (apoptotic index of 0.1–0.3; Figs. 3 and 4 C). The
expression levels of PYK2, FAK, FAK-Y397F, and FRNK
were similar based on Western blot analysis of extracts
from the transfected cells (Fig. 4 B). The transfection effi-
ciencies using these constructs were similar (data not
shown).
The putative FAT domain of PYK2 did not appear to be
critical for the apoptotic activity. Partial deletion of the
FAT domain, PYK2D936-1009, did not inhibit induction
of apoptosis (apoptotic index of 0.99; Figs. 3 and 4), yet
this mutant protein failed to bind to paxillin and localize to
focal contacts (data not shown). Paradoxically, transfec-
tion of mutant cDNAs encoding the entire COOH-terminal
domain (PYK2D1-680) or cDNAs encoding only the COOH-
terminal FAT domain (PYK2D1-781 and PYK2D1-868)
still retained low but reproducible apoptotic activity (Figs.
3 and 4). These data suggested that while expression of ei-
ther the NH2 or COOH terminus alone could induce lim-
ited apoptosis, the full apoptotic activity required both an
intact NH2 terminus and active kinase domain.
To confirm that PYK2-KD was catalytically inactive, we
studied autophosphorylation of wild-type PYK2-WT and
mutants (PYK2-KD, PYK2D1-88, PYK2D1-416, PYK2D936-
1009, and PYK2-Y402F) by immunoblotting using an-
tiphosphotyrosine antibodies. While the PYK2-WT was
highly tyrosine phosphorylated, the PYK2-KD failed to
react with antiphosphotyrosine antibodies (Fig. 5 B), indi-
cating that PYK2-KD was kinase inactive. The autophos-
Figure 4. Apoptotic activities and Western blotting of PYK2,
PYK2 mutants, FAK, and FAK mutants. (A) Western blotting of
HEK 293 cells expressing proteins of PYK2 and PYK2 mutants
using antibodies against PYK2 and c-Myc epitope. The position
of protein molecular weight markers is indicated at the right. (B)
Western blotting of HEK 293 cells expressing proteins of PYK2,
FAK, and FAK mutants using antibodies against c-Myc epitope.
The position of protein molecular weight markers is also indi-
cated at the right. (C) Histograms of the apoptotic index of cells
transfected with constructs encoding PYK2, PYK2 mutants,
FAK, and FAK mutants. Apoptotic index (mean 6 SEM) was
determined by counting the apoptotic PYK2 or FAK-expressing
cells (or PYK2-positive) divided by total number of PYK2 or
FAK expression cells.The Journal of Cell Biology, Volume 139, 1997 534
phorylation site of PYK2 may be tyrosine 402 (Y402), a
residue also conserved in FAK (Y397) that became phos-
phorylated upon FAK activation. The Y402 mutant (PYK2-
Y402F) and the NH2-terminal deletion mutant PYK2D1-416,
in which the autophosphorylation site (Y402) was deleted,
also did not react with antiphosphotyrosine antibodies
(Fig. 5 B). Interestingly, the partial NH2-terminal deletion
mutant (PYK2D1-88) with reduced apoptotic index also
exhibited reduced tyrosine phosphorylation (Fig. 5, B and C).
To further examine the mechanisms by which PYK2,
but not FAK, induces apoptosis, we constructed a chi-
meric protein (PYK2/FAK1) containing the NH2-terminal
domain of PYK2 (amino acids 2 to 385) and the catalytic
and COOH-terminal domains of FAK (amino acids 380 to
1,052) and a second chimeric protein (PYK2/FAK2) con-
taining the NH2-terminal and kinase domains of PYK2
(amino acids 2 to 695) and the COOH-terminal domain of
FAK (amino acids 692 to 1,052; Fig. 6 A). The structure of
these chimeric constructs (PYK2/FAK1 and PYK2/FAK2)
was confirmed by Western blotting analysis of HEK 293
cell lysates overexpressing PYK2, PYK2/FAK1, PYK2/
FAK2, and FAK using antibodies against c-Myc epitope,
PYK2 NH2-terminal domain (anti-PYK2 from Santa Cruz
Biotechnology), and FAK COOH-terminal domain (mAb
2A7; Fig. 6 B). Apoptotic activities of these chimera were
examined in rat-1 cells. Both PYK2/FAK1 and PYK2/
FAK2 demonstrated similar apoptotic activities (apoptotic
index of 0.8 to 0.84) as wild-type PYK2, while the apop-
totic activity of wild-type FAK was close to the basal level
(0.13; Fig. 6 C). These data indicated that the NH2-termi-
nal domain of PYK2 was sufficient to render FAK indis-
tinguishable from PYK2 in its ability to induce apoptosis.
PYK2-mediated Apoptosis Can
Be Suppressed by Over-Expression of Catalytically
Active Src, PI3 Kinase, and Akt
To examine the possible effects of Src on PYK2-mediated
Figure 5. Catalytic and apop-
totic activity of wild-type and
mutant PYK2. (A) Schematic
representation of PYK2 and
its mutants. The numbers
represent the amino acid res-
idues mutated from wild-type
PYK2. The shaded block rep-
resents the kinase domain of
PYK2. The putative FAT
domain and proline-rich se-
quences are indicated. The
constructs tagged with c-Myc
are also indicated. The tyrosine
phosphorylation and the apop-
totic index of these mu-
tants  are listed in the right-
hand column. (B) Tyrosine
phosphorylation of wild-type
PYK2 (PYK2-WT), kinase-
inactive PYK2 (PYK2-KD),
the putative FAT domain dele-
tion mutant (PYK2D936-1009),
the NH2-terminal domain
deletion mutants (PYK2D1-88
and PYK2D1-416), and the
autophosphorylation site mu-
tant (PYK2-Y402F). Cell
lysates from 293 cells
overexpressing PYK2-WT,
PYK2-KD, PYK2D936-1009,
PYK2D1-88, PYK2D1-416,
and PYK2-Y402F proteins
were immunoprecipitated by
antibodies against PYK2. The
immunoprecipitatied proteins
were then subjected to immu-
noblotting with the antibod-
ies against phosphotyrosine
(anti-P-tyr) or PYK2 (anti-
PYK2). (C) Histograms of
apoptotic index of PYK2D936-
1009, PYK2D1-88, PYK2-WT,
PYK2-KD, PYK2D1-416, and
PYK2-Y402F.Xiong and Parsons PYK2 Induces Apoptosis 535
apoptosis, we expressed PYK2 in LA29 cells, a tempera-
ture-sensitive v-Src rat-1 cell line. When PYK2-WT was
transiently expressed in LA29 cells grown at permissive
temperature (358C), the apoptotic index was significantly
reduced from 0.97 to 0.25 (Fig. 7). No significant inhibition
of apoptosis was observed when LA29 cells expressing
PYK2 were grown at nonpermissive temperature (398C)
(data not shown), indicating that the tyrosine kinase activity
of v-Src was required for this event. To examine whether
suppression of apoptosis could be mimicked by c-Src,
PYK2 was transiently expressed in mouse 10T1/2 cells
stably over-expressing c-Src (5H), as well as its parental
10T1/2 cells. 10T1/2 cells expressing full length PYK2 un-
derwent apoptosis (apoptotic index of 0.95). The apoptotic
index was significantly reduced to 0.45 when PYK2 was
expressed in the c-Src (5H) cell line (Fig. 7). To determine
if the reduced apoptotic index of c-Src was dependent on
kinase activity, PYK2 was transiently expressed in cells
stably over-expressing either catalytically inactive c-Src
(pm430 mutant) or an SH2-defective variant of c-Src
(dl155; Wilson et al., 1989). The extent of cell death (apop-
totic index of 0.98) mediated by PYK2 in cells expressing
catalytically inactive Src, was not appreciably different
from the parental 10T1/2 cells (Fig. 5). However, in the
SH2-defective c-Src cell line (dl155), the apoptotic index
was significantly reduced to 0.55 (Fig. 7). These results
suggested that the catalytic activity, but not the SH2 do-
main of c-Src, appeared to be required for the suppression
of PYK2-mediated apoptosis in fibroblasts.
We next examined the effects of PI3 kinase on PYK2-
mediated apoptosis. The plasmids encoding c-Myc–tagged
constitutively active or catalytically inactive P110/PI3 ki-
nases, in which a truncated p85 subunit was linked to the
catalytic subunit (Hu et al., 1995), were cotransfected in
rat-1 cells with wild-type PYK2. Co-expression of the con-
stitutively active PI3 kinase (PI3K) significantly reduced
the apoptotic effects of PYK2 (apoptotic index of 0.59;
Fig. 8). The reduction in PYK2-induced apoptosis was not
Figure 6. Apoptotic activity
of PYK2/FAK chimeric fu-
sion proteins. (A) Schematic
representation of PYK2,
PYK2/FAK1, PYK2/FAK2,
and FAK. The shaded block
represents the regions of
PYK2. The open block rep-
resents the regions of FAK.
The numbers represent the
number of amino acids in
FAK or PYK2. The kinase
domain sequence is indi-
cated. The constructs tagged
with c-Myc are also indi-
cated. NH2-terminal domain
of PYK2 (amino acid 2 to
385) was fused with the ki-
nase and COOH-terminal
domains of FAK (amino ac-
ids 380 to 1,052) in construct
PYK2/FAK1. In construct
PYK2/FAK2, PYK2 (amino
acids 2 to 695) was fused with
FAK (amino acids 692 to
1,052). The apoptotic index
of these PYK2/FAK chi-
meric proteins was listed in
the right-hand column. (B)
Western blotting of HEK 293
cells expressing PYK2,
PYK2/FAK1, PYK2/FAK2,
and FAK proteins using anti-
bodies against cMyc epitope,
goat anti-PYK2 (from Santa
Cruz Biotechnology; recog-
nizing epitope in PYK2 NH2-
terminal domain), or FAK
(2A7, recognizing epitope in
FAK COOH-terminal do-
main). (C) Histograms of the
apoptotic index of rat-1 cells
transfected with FAK-WT,
PYK2/FAK1, PYK2/FAK2,
and PYK2-WT.The Journal of Cell Biology, Volume 139, 1997 536
observed when the catalytically inactive PI3 kinase (PI3KD)
was cotransfected into rat-1 cells (Fig. 8), indicating that
the catalytic activity of PI3 kinase was required for sup-
pression of apoptosis. The expression of catalytically ac-
tive (PI3K) and inactive (PI3KD) PI3 kinases was exam-
ined by immunostaining using antibodies against the c-Myc
epitope and p85 subunit of PI3 kinase.
The serine/threonine protein kinase Akt (also called
protein kinase B, PKB) is believed to be one of the effec-
tors in the PI3 kinase signaling pathway (Burgering and
Coffer, 1995; Franke et al., 1995). Activation of Akt can
protect many cells against apoptosis, whereas inhibition of
Akt does not (Dudek et al., 1997; Kauffmann-Zeh et al.,
1997; Kulik et al., 1997). To further confirm the suppres-
sive effects of PI3 kinase in PYK2-induced apoptosis, we
determined if activated Akt was able to protect cells
against PYK2-induced apoptosis. The plasmids encoding
HA-tagged constitutively active Akt/PKB, in which Akt
Figure 7. Suppression of the PYK2-induced apoptosis by overex-
pression of catalytically active Src. Wild-type PYK2 was tran-
siently transfected into different cell lines stably expressing wild-
type Src and various Src mutants. (A) Immunostaining of PYK2
with anti–c-Myc antibodies (9E10 mAB) in rat-1, temperature-
sensitive v-Src (ts v-Src, LA29), 10T1/2, c-Src (5HD47), kinase-
dead c-Src (430), and SH2-defective c-Src (c-Src dSH2, dl155) cell
lines expressing wild-type c-Myc–tagged PYK2. (B) Histograms
of apoptotic index mediated by wild-type PYK2 in different Src
cell lines.
Figure 8. Suppression of PYK2-induced apoptosis by overex-
pression of active PI3 kinase and Akt. Full length PYK2 was
cotransfected into rat-1 cells with constitutively active and inac-
tive PI3 kinase (PI3K, PI3KD) and active and inactive Akt (Akt,
AktD; at 1:1 molar ratio of DNA). (A) Cotransfected cells were
doubly immunostained using antibodies against PYK2 (a, c, e,
and g), p85 subunit for PI3 kinase (b and d), and HA-epitope for
Akt proteins (f and h). (B) Histograms of the apoptotic index me-
diated by cotransfection of PYK2-WT with vector alone (1), ac-
tive PI3 kinase (2), inactive PI3 kinase (3), active Akt (4), inac-
tive Akt (5), crmA (6), and Bcl2 (7).Xiong and Parsons PYK2 Induces Apoptosis 537
was targeted to the membrane by myristoylation, or cata-
lytically inactive Akt were cotransfected in rat-1 cells with
wild-type PYK2. Co-expression of the active Akt signifi-
cantly reduced the apoptotic effects of PYK2 (apoptotic
index of 0.58; Fig. 8), whereas catalytically inactive Akt
did not (Fig. 8). These data demonstrated that active Akt
was able to at least partially block PYK2-induced apopto-
sis. In addition, we also examined the effects of other cell
death suppressors on PYK2-induced apoptosis. CrmA, an
ICE-like proteinase inhibitor, was able to efficiently sup-
press PYK2-induced cell death (apoptotic index of PYK2
was reduced to 0.4, when crmA was cotransfected with
wild-type PYK2; Fig. 8 B). In contrast, overexpression of
Bcl2, another cell death suppressor, did not block the
PYK2-induced cell death (Fig. 8 B).
Discussion
In this study, we have investigated the expression of the
FAK-related protein tyrosine kinase, PYK2, in several dif-
ferent fibroblastic and epithelial cell lines including rat-1,
mouse 10T1/2, and HEK 293 cells. In each cell line the
forced expression of PYK2, but not the related tyrosine ki-
nase, FAK, rapidly (within 24 to 30 h) induced apoptosis.
Apoptosis induced by expression of full length PYK2 was
very efficient; .90% of the cells expressing PYK2 undergo
programed cell death. In contrast, mutant forms of PYK2
deficient in kinase activity (PYK2-KD) or lacking the ma-
jor site of autophosphorylation (PYK2-Y402F) were sig-
nificantly less efficient in inducing apoptosis, reducing the
overall level of cell death from .90% to 40–58%. Chi-
meric proteins containing the NH2-terminal domain of
PYK2 and the kinase and COOH-terminal domains of
FAK were as efficient as wild-type PYK2 in the induction
of apoptosis. Co-expression of PYK2 with either active
Src, PI3 kinase, or the serine/threonine kinase, Akt, signif-
icantly reduced apoptosis. In addition, co-expression of
PYK2 with crmA, an inhibitor of the ICE or ICE-like pro-
teinases, but not Bcl2, also significantly inhibited apopto-
sis. We conclude from these data that the efficient induc-
tion of cell death by PYK2 under our assay conditions,
requires specific interactions via sequences in the NH2-ter-
minal domain of PYK2, PYK2 kinase activity, and the
ability to autophosphorylate at tyrosine residue 402. In ad-
dition, efficient induction of cell death requires that PYK2
functionally interacts with a downstream signaling path-
way(s) (may be mediated in part by inhibition of the PI3
kinase pathway) to promote apoptosis.
The high apoptotic activity exhibited by the chimeric
constructs PYK2/FAK1 and PYK2/FAK2 point to the im-
portance of the NH2-terminal domain of PYK2 in inducing
apoptosis. Furthermore, these observations argue that the
catalytic and COOH-terminal domains of PYK2 and FAK,
while necessary for the apoptotic process, are interchang-
able. Expression of the PYK2 NH2- and COOH-terminal
domains also induces apoptosis, albeit with an efficiency
significantly less than full length PYK2, but comparable to
catalytically inactive PYK2 (Fig. 3). While it is unclear
how these isolated domains induce apoptosis, studies of
FAK demonstrate that the NH2- and COOH-terminal do-
mains interact with several well characterized binding
partners, linking FAK to both upstream and downstream
signaling pathways (Schaller and Parsons, 1994). Thus we
speculate that apoptosis induced by forced expression of
the chimeric proteins, the NH2-terminal, and COOH-ter-
minal domains of PYK2 may result from the activation of
signaling pathways that lead to the apoptotic process, or/
and the inhibition of signaling pathways whose continuity
is required to maintain cell viability. What these pathways
might be remains unclear, particularly in light of the pau-
city of data regarding the function of PYK2 in different
cell types.
Co-expression of full length PYK2 with either constitu-
tively active PI3 kinase, Akt, or Src results in the partial
rescue of PYK2-induced apoptosis (Fig. 6). These data im-
plicate the PI3 kinase pathway in the protection of apopto-
sis mediated by wild-type PYK2. Akt is a serine/threonine
protein kinase (also called protein kinase B or PKB), iden-
tified first as an oncogene; however, recent studies indi-
cate that it is one of the major targets of PI3 kinase (Bur-
gering and Coffer, 1995; Franke et al., 1995). The fact that
Akt can substitute for activated PI3 kinase in protection of
PYK2-induced apoptosis lends further support for the role
of PI3 kinase signaling in protection of PYK2-induced apop-
tosis. Finally, v- and c-Src also partially suppress PYK2-
mediated apoptosis. The fact that PI3 kinase is activated
by Src (Fukai and Hanafusa, 1989) and that catalytically
active Src is required for rescue of PYK2-induced apopto-
sis, leads us to speculate that activation of PI3 kinase by
Src may be a possible mechanism for Src-mediated rescue.
Thus one possible mechanism by which PYK2 might in-
duce apoptosis is by inhibiting PI3 kinase either directly
(perhaps by a phosphorylation-dependent mechanism) or
indirectly by negatively regulating an upstream effector of
PI3 kinase activation. This suggestion is supported by re-
cent observations that PI3 kinase activity is required for
PC12 cell survival mediated by growth factors including
NGF and PDGF (Valius and Kazlauskas, 1993; Yao and
Cooper, 1995) and that active Akt is able to rescue the
apoptosis induced by c-Myc over-expression in fibroblasts
(Kauffmann-Zeh et al., 1997), serum withdrawal in neu-
ronal cells (Dudek et al., 1997), and UV light in Cos-1 cells
(Kulik et al., 1997).
The results presented herein are the first report of a role
for PYK2 in the induction of apoptosis. PYK2 is present at
relatively high levels in brain and is expressed in kidney,
liver, spleen, and a variety of cell lines (e.g., PC12 cells and
many hematopoietic cell lines; Avraham et al., 1995; Salgia
et al., 1996; Sasaki et al., 1995). Elevated expression of
PYK2 has been reported in GN4, a transformed rat liver
epithelial cell line (Yu et al., 1996). In PC12 and GN4 cells,
PYK2 activation appears to be linked to neurotransmit-
ters, growth factors, and hormones that induce alterations
in calcium-dependent signaling pathways (Lev et al., 1995;
Yu et al., 1996). The cell lines used in this study (rat-1,
mouse 10T1/2, and HEK 293 cells) exhibit low levels of en-
dogenous PYK2 expression. Therefore it is unlikely that
PYK2 plays a role in regulating apoptotic pathways in
these cells. More likely is the possibility that PYK2 expres-
sion in these cells is mediating an inappropriate regulation
of an existing signaling pathway (such as PI3 kinase), lead-
ing to the perturbation of a signaling pathway required for
normal cell viability. Interestingly, no apoptosis was ob-
served when PYK2 was overexpressed in PC12 cells whereThe Journal of Cell Biology, Volume 139, 1997 538
there is significant level of endogenous PYK2. Whether
PYK2 can function to trigger apoptosis in cells in which it
is normally expressed remains to be examined.
In summary, PYK2 appears to mediate different func-
tions from those of FAK, a related protein tyrosine kinase.
Ectopic expression of PYK2 led to apoptosis in several fi-
broblastic and epithelial cell lines, whereas over-expression
of FAK did not result in cell death in any of these cell lines
tested. The different effects of PYK2 and FAK on cell
growth suggest that these two protein tyrosine kinases, in
spite of similarity in overall structure, may mediate signal-
ing via different pathways. Experiments to understand the
mechanisms for the opposite effects mediated by PYK2
and FAK are in progress.
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